Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.22.B71 extracted from

  • Tan, M.; Gong, H.; Wang, J.; Tao, L.; Xu, D.; Bao, E.; Liu, Z.; Qiu, J.
    SENP2 regulates MMP13 expression in a bladder cancer cell line through SUMOylation of TBL1/TBLR1 (2015), Sci. Rep., 5, 13996 .
    View publication on PubMedView publication on EuropePMC

Application

Application Comment Organism
medicine in bladder cancer cells, SENP2 inhibits MMP13 expression through deSUMOylation of TBL1/TBLR1, which inhibits nuclear translocation of beta-catenin Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens Q9HC62
-
-

Source Tissue

Source Tissue Comment Organism Textmining
T-24 cell bladder cancer cell line Homo sapiens
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
SUMOylated TBL1/TBLR1 + H2O i.e. transcriptional cofactor transducin beta-like Homo sapiens ?
-
?

General Information

General Information Comment Organism
physiological function SENP2 inhibits nuclear translocation of beta-catenin, which targets the promotor of MMP13 to activate MMP13 to enhance bladder cancer cell metastasis Homo sapiens